Investor directory

Evidera

Evidera provides health economics, outcomes research, market access, data analytics and epidemiology services. We partner with life sciences organizations worldwide to optimize the market access and commercial success of their products by leveraging our unparalleled knowledge of the global payer and regulator landscape and by developing, capturing and communicating the clinical and economic evidence that our clients require to successfully market their products. Our research and consulting services are driven by world-class science and thought leadership and leverage a unique combination of capabilities.

Top Stages

Acquisition
http://evidera.com
https://crunchbase.com/organization/evidera
https://facebook.com/ppdcro
https://linkedin.com/company/evidera
https://pitchbook.com/profiles/company/57866-32
https://twitter.com/evideraglobal

Karen Kaucic MD

President

2 past transactions

Medimix International

Acquisition in 2019
Medimix International is a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic and medical device industries. Our solutions leverage big data and evidence-based information, to advise and support business decisions in forecasting, marketing, commercial analytics, business intelligence, health economics, medical affairs, strategy and licensing.

Archimedes

Acquisition in 2014
Archimedes is a healthcare modeling organization that offers Archimedes Model, a mathematical model of human physiology, diseases, interventions, and healthcare systems. The Archimedes Model is designed to help people understand the implications of their decisions and find answers to complex, real-world questions for health plans, pharmaceutical companies, researchers, and other organizations. Archimedes was founded in 1980 and is based in San Francisco, California.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.